These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Statins and diabetes--indications and refusal rules]. Claudi T; Birkeland K; Jensen T Tidsskr Nor Laegeforen; 2003 May; 123(11):1564-5. PubMed ID: 12822023 [No Abstract] [Full Text] [Related]
4. Should women with normal cholesterol be taking a statin? A major study suggests that statins also quell inflammation. Now what? Harv Womens Health Watch; 2009 Feb; 16(6):1-3. PubMed ID: 19297742 [No Abstract] [Full Text] [Related]
5. Statins indispensable for people with diabetes. Health News; 2003 Aug; 9(8):6. PubMed ID: 12971317 [No Abstract] [Full Text] [Related]
6. [A too optimistic report of a new study on statins]. Ravnskov U Lakartidningen; 2002 Feb; 99(9):949-51. PubMed ID: 11962023 [No Abstract] [Full Text] [Related]
7. [Pfizer: TLV decision about antilipemic agents is founded on wrong basis]. Brun J; Ohlsson-Onerud A; Sörensen N Lakartidningen; 2009 Apr 22-28; 106(17):1193-4; discussion 1194. PubMed ID: 19530431 [No Abstract] [Full Text] [Related]
8. [Statins in practice of the vascular surgeon and cardiologist]. Pokrovskiĭ AV; Suntsov DS Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952 [TBL] [Abstract][Full Text] [Related]
9. [Conflict of interest and therapy recommendations]. Laake JH Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2663-4; author reply 2664. PubMed ID: 15534654 [No Abstract] [Full Text] [Related]
10. Commentary on "Influence of industry on renal guideline development". Campbell D; Walker R; Mathew T; Craig J Clin J Am Soc Nephrol; 2007 Mar; 2(2):211. PubMed ID: 17699413 [No Abstract] [Full Text] [Related]
11. Separating practice guidelines from pharmaceutical marketing. Eichacker PQ; Natanson C; Danner RL Crit Care Med; 2007 Dec; 35(12):2877-8; author reply 2878-80. PubMed ID: 18043217 [No Abstract] [Full Text] [Related]
12. [Statins--are there differences when it comes to clinical effect?]. Madsen S; Reikvam A Tidsskr Nor Laegeforen; 2001 Mar; 121(8):948-50. PubMed ID: 11332385 [No Abstract] [Full Text] [Related]
13. [SBU should investigate what is an evidence-based and cost-effective use of statins]. Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B Lakartidningen; 2009 Aug 5-18; 106(32-33):1992-4. PubMed ID: 19764381 [No Abstract] [Full Text] [Related]
14. Influence of industry on renal guideline development. Coyne DW Clin J Am Soc Nephrol; 2007 Jan; 2(1):3-7; discussion 13-4. PubMed ID: 17699377 [No Abstract] [Full Text] [Related]
15. Principles for national and regional guidelines on cardiovascular disease prevention. Smith S; Voûte J; Fuster V Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):461. PubMed ID: 16932757 [No Abstract] [Full Text] [Related]
16. Preface cardiovascular disease prevention: the continuum of primary and secondary prevention. Deedwania P Cardiol Clin; 2011 Feb; 29(1):xi-xiii. PubMed ID: 21257096 [No Abstract] [Full Text] [Related]
17. [Misuse of the DSAM name]. Friborg S Ugeskr Laeger; 2003 Oct; 165(41):3940; author reply 3940. PubMed ID: 14579561 [No Abstract] [Full Text] [Related]
18. Through the looking glass: anemia guidelines, vested interests, and distortions. Ingelfinger JR Clin J Am Soc Nephrol; 2007 May; 2(3):415-7. PubMed ID: 17699445 [No Abstract] [Full Text] [Related]
19. [Conflict of interest]. Heinzl S Med Monatsschr Pharm; 1998 Feb; 21(2):29. PubMed ID: 9531788 [No Abstract] [Full Text] [Related]
20. [What would you do?]. Hedlund K Lakartidningen; 2005 May 2-15; 102(18-19):1467-8; author reply 1468. PubMed ID: 15929438 [No Abstract] [Full Text] [Related] [Next] [New Search]